248 related articles for article (PubMed ID: 36126797)
1. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
2. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
[TBL] [Abstract][Full Text] [Related]
3. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
4. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl
He C; Shu B; Zhou Y; Zhang R; Yang X
Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
6. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.
Wang H; Wang Z; Wang Y; Li X; Yang W; Wei S; Shi C; Qiu J; Ni M; Rao J; Cheng F
J Cell Mol Med; 2021 Aug; 25(15):7381-7394. PubMed ID: 34272822
[TBL] [Abstract][Full Text] [Related]
7. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
[TBL] [Abstract][Full Text] [Related]
8. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.
Lu H; Zhang R; Zhang S; Li Y; Liu Y; Xiong Y; Yu X; Lan T; Li X; Wang M; Liu Z; Zhang G; Li J; Chen S
Int Immunopharmacol; 2023 Nov; 124(Pt B):111002. PubMed ID: 37804655
[TBL] [Abstract][Full Text] [Related]
9. PGE
Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
Li G; Li J; Li C; Qi H; Dong P; Zheng J; Yu F
Cell Physiol Biochem; 2016; 38(4):1544-52. PubMed ID: 27074047
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression.
Wang Q; Wei S; Zhou H; Li L; Zhou S; Shi C; Shi Y; Qiu J; Lu L
Front Cell Dev Biol; 2020; 8():513. PubMed ID: 32637414
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
16. miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1.
Pan W; Wang Y; Zhao C
Scand J Gastroenterol; 2023; 58(11):1335-1343. PubMed ID: 37313731
[TBL] [Abstract][Full Text] [Related]
17. Dual Targeting of Angipoietin-1 and von Willebrand Factor by microRNA-671-5p Attenuates Liver Angiogenesis and Fibrosis.
Yang L; Yue W; Zhang H; Zhang Z; Xue R; Dong C; Liu F; Chang N; Yang L; Li L
Hepatol Commun; 2022 Jun; 6(6):1425-1442. PubMed ID: 35014213
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34b-5p binds enhancer of zeste 2 to inhibit milk fat globule-EGF factor 8 expression, affecting liver fibrosis.
Ma J; Liu Q; Chen M; He B; Li Y; Zhang M; Jiang Y
J Physiol Biochem; 2022 Nov; 78(4):885-895. PubMed ID: 36138295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
